Project Ambrosia / Available
Available for purchaseCash-pay telehealth platform for GLP-1 weight loss and longevity care
Asset-light, subscription-style telemedicine run by an in-house clinical team of nurse practitioners licensed in all 50 states, with partner pharmacies shipping directly to patients and no inventory held at any point.
Sector
Telehealth (Weight Loss & Longevity)
Cash-pay, subscription model
Geography
United States
Fully remote, all 50 states served
Revenue
$1.82M
TTM to May 2026, +36% YoY
SDE
$633K
TTM SDE, QoE-compiled P&L
SDE Margin
~35%
TTM SDE margin
Employees
~10
Operator, support and contract clinicians
Investment Highlights
Why buyers are looking at this deal
- Affiliate-led acquisition has been the only growth lever pulled to date: hiring a dedicated affiliate manager roughly doubled monthly revenue in four months, with no paid advertising spend.
- Owner independence is already built in: an operator, an affiliate manager and an in-house clinical team run the day to day, leaving roughly five hours of owner time per month.
- Asset-light by design, with partner pharmacies shipping directly to patients, so no inventory, facility or capex is required to add volume.
- Consistent profitability at a 66% TTM gross margin, alongside certified but unused paid-ad accounts, an insurance channel and new clinical protocols that remain untouched.